Barbara Ensoli

Barbara Ensoli, M.D., Ph.D., graduated in Medicine and Surgery and specialized in Clinical Immunology and Allergy at the University of Rome “La Sapienza”, Italy. She then spent more than 11 years at the National Institute of Health (Bethesda, Maryland, USA), working at the National Cancer Institute. During those years she elucidated the role of the HIV-1 Tat protein in HIV pathogenesis and AIDS-associated tumors.
Her current research interests are HIV pathogenesis and the development of HIV/AIDS preventative and therapeutic vaccines, which are currently in advanced clinical phase. She has coordinated several international and national research programs in Europe and Developing countries. Among them, the EU-funded "AIDS Vaccine Integrated Project" (AVIP) and the “Program to support the Ministry of Health of South Africa in the implementation of a national program of global response to HIV & AIDS” (Italian Ministry of Foreign Affairs), which is currently ongoing.
She is a member of the WHO-UNAIDS Vaccine Advisory Committee and the European Molecular Biology Organisation (EMBO). She is the Vice-President of the National AIDS Committee of the Italian Ministry of Health and Member of the Editorial Board of the Health Status Report 2011 (RSSP), Ministry of Health (2012).
She sits on the editorial boards of Lancet Oncology, PLoS ONE, The Open AIDS Journals, Tumor Viruses, Vaccine: Development and Therapy, Journal of Clinical & Cellular Immunology, Advances in Tumor Virology.
She has received several national and international scientific awards and she has been appointed as Ufficiale dell’Ordine al Merito della Repubblica Italiana in 2001 by the President of the Italian Republic Mr. A. Ciampi.
Her scientific activities have resulted in more than 300 publications in peer-reviewed journals.